Structural characterization of a clinically described heparin-like substance in plasma causing bleeding.

Carbohydrate Polymers
Yanlei YuRobert J Linhardt

Abstract

Heparin-like substances (HLS) have been described in various clinical situations, including in settings of liver disease associated with infection, transplant, and metastasis. HLS are generally attributed to circulating glycosaminoglycans. Initial results for this patient showed coagulopathy due to liver disease without HLS. Two weeks after liver transplantation, a 10 year-old female with liver failure patient began to bleed from catheter insertion sites, mouth, and nares and HLS was suspected. The patient subsequently died and these clinical samples resulted in the isolation of a single heparan sulfate (HS) present at high concentrations in the plasma. Analysis of this HS showed it had an intermediate between heparin and HS with low antithrombin-mediated anticoagulant activity. We speculate that this 10-year old patient might have a platelet function defect influenced by this unusual HS. Endothelial defects not measurable by our methods might have also contributed to the observed bleeding complications.

References

Sep 1, 1978·The Histochemical Journal·M A Derby, J E Pintar
May 1, 1995·General Pharmacology·R J Linhardt, R E Hileman
Jun 5, 2002·Annual Review of Biochemistry·Jeffrey D Esko, Scott B Selleck
Sep 6, 2002·Glycobiology·Janet M Trowbridge, Richard L Gallo
Jun 13, 2003·Journal of Medicinal Chemistry·Robert J Linhardt
Sep 29, 2006·Glycoconjugate Journal·Mohamad WardaRobert J Linhardt
Apr 7, 2007·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Lamia TorjemaneAbdeladhim Ben Abdelhadhim
Feb 18, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Marco SenzoloAndrew K Burroughs
Feb 27, 2009·The Journal of Biological Chemistry·Xiaofeng Shi, Joseph Zaia
Oct 16, 2009·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Kelly N FahlMitchell C Benson
Mar 7, 2012·Applied Microbiology and Biotechnology·Paul L DeAngelis
May 9, 2012·Handbook of Experimental Pharmacology·Menaka Pai, Mark A Crowther
Mar 26, 2013·Journal of Pharmaceutical Sciences·Li FuRobert J Linhardt
Feb 11, 2014·The Journal of Biological Chemistry·Eric P SchmidtRobert J Linhardt
Jul 22, 2014·Angewandte Chemie·Cheng-Hsiu ChangShang-Cheng Hung
Feb 15, 2015·ACS Chemical Biology·Guoyun LiRobert J Linhardt
Oct 31, 2015·Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine·Martin PonschabHerbert Schöchl
Nov 12, 2015·Advanced Drug Delivery Reviews·Li FuRobert J Linhardt
Apr 23, 2016·Frontiers in Bioscience (Landmark Edition)·Akihiro OnishiRobert J Linhardt
Oct 17, 2016·Glycobiology·Yanlei YuRobert J Linhardt
Dec 23, 2016·Journal of Pharmaceutical Sciences·Yin ChenRobert J Linhardt
Jan 22, 2018·Carbohydrate Polymers·Yusuke OkamotoToshihiko Toida
Apr 21, 2018·Arteriosclerosis, Thrombosis, and Vascular Biology·Amélie I S SobczakAlan J Stewart
May 12, 2019·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Madhumita PremkumarShiv Kumar Sarin
Nov 13, 2019·Accounts of Chemical Research·Xing ZhangRobert J Linhardt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.